ITGB4 promotes the progression of colorectal cancer by activating Wnt/β-catenin signaling pathway via targeting EZR
Jing Wang,Yi Si,Mingda Xuan,Shuangshuang Han,Kunyi Liu,Jiao Jiao,XiaoYan Men,HongFei Li,Weifang Yu,Ting Liu,Jia Wang
DOI: https://doi.org/10.1101/2024.12.19.629152
2024-12-21
Abstract:Background: Integrin Beta 4 (ITGB4), a member of the integrin family, was found to be abnormally highly expressed in colorectal cancer tissues and serum in our previous research, and it was associated with clinicopathological types and overall survival. This study further explores the potential mechanisms of ITGB4 in the occurrence and development of colorectal cancer, seeks downstream target genes and signaling pathways, and provides new insights for precision treatment of colorectal cancer.
Methods: Through bioinformatics analysis, it was verified that ITGB4 and EZR are highly expressed in tumor tissues of CRC patients and are associated with poor patient prognosis. The effects of ITGB4 on the proliferation, migration, invasion, and apoptosis of CRC cells were validated using CCK-8, wound healing assay, Transwell migration, and invasion assays. A nude mouse tumor formation experiment was conducted to validate the tumor-promoting effect of ITGB4 in vivo. Transcriptome sequencing was performed in SW480 cells with ITGB4 knockdown, and potential downstream targets and signaling pathways of ITGB4 were screened using KEGG enrichment analysis and bioinformatics analysis. The interaction between ITGB4 and downstream target genes was further demonstrated by immunofluorescence co-staining and co-immunoprecipitation. Key proteins in the downstream signaling pathway (β-catenin, c-Myc, and cyclinD1) were detected by Western blot to clarify the potential signaling pathway through which ITGB4 functions in CRC. Rescue experiments were conducted to validate the role of ITGB4 and its downstream target genes in the proliferation, migration, and invasion of colorectal cancer.
Results: ITGB4 is highly expressed in CRC tissues and cells. In vitro, downregulation of ITGB4 can inhibit the proliferation, migration, and invasion of CRC cells and promote apoptosis. In vivo, ITGB4 contributes to the growth of CRC tumor tissues and regulates the tumorigenic properties such as proliferation and invasion of CRC cells. Additionally, EZR has been preliminarily identified as a key downstream target of ITGB4, as the effects of ITGB4 knockdown on the proliferation, migration, and invasion of CRC cells can be rescued by overexpressing EZR. We also demonstrated that the ITGB4/EZR axis promotes the occurrence and development of CRC by activating the Wnt/β-catenin signaling pathway and regulating various biological functions of CRC cells.
Conclusions: ITGB4 targets and regulates EZR, and by activating the Wnt/β-catenin signaling pathway, it affects the proliferation, migration, and invasion of CRC, suggesting that ITGB4 may become a potential biomarker and therapeutic target.
Molecular Biology